|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
956,580,000 |
Market
Cap: |
869.57(B) |
Last
Volume: |
1,947,382 |
Avg
Vol: |
3,268,697 |
52
Week Range: |
$434.7 - $909.04 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 720 |
Guru Rank Value : 1.4 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
656 |
Total Buy Value |
$0 |
$0 |
$0 |
$199,549 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
1,520,577 |
2,391,327 |
3,815,444 |
6,318,238 |
Total Sell Value |
$1,284,658,855 |
$1,892,909,435 |
$2,147,483,647 |
$2,147,483,647 |
Total People Sold |
3 |
3 |
4 |
6 |
Total Sell Transactions |
18 |
31 |
51 |
93 |
End Date |
2024-03-30 |
2023-12-28 |
2023-06-29 |
2022-06-29 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lilly Endowment Inc |
10% Owner |
|
2018-08-30 |
4 |
S |
$105.42 |
$20,030,370 |
D/D |
(190,000) |
119,970,804 |
|
- |
|
Lilly Endowment Inc |
10% Owner |
|
2018-08-20 |
4 |
S |
$105.89 |
$20,647,575 |
D/D |
(195,000) |
120,160,804 |
|
- |
|
Fyrwald J Erik |
Director |
|
2018-08-20 |
4 |
A |
$105.82 |
$5,397 |
D/D |
51 |
59,401 |
|
- |
|
Luciano Juan R |
Director |
|
2018-08-20 |
4 |
A |
$105.82 |
$9,630 |
D/D |
91 |
6,302 |
|
- |
|
Alvarez Ralph |
Director |
|
2018-08-20 |
4 |
A |
$105.82 |
$10,899 |
D/D |
103 |
41,071 |
|
- |
|
Lilly Endowment Inc |
10% Owner |
|
2018-08-16 |
4 |
S |
$104.50 |
$20,899,800 |
D/D |
(200,000) |
120,355,804 |
|
- |
|
Lilly Endowment Inc |
10% Owner |
|
2018-08-15 |
4 |
S |
$103.23 |
$15,669,440 |
D/D |
(151,793) |
120,555,804 |
|
- |
|
Lilly Endowment Inc |
10% Owner |
|
2018-08-10 |
4 |
S |
$103.06 |
$369,676 |
D/D |
(3,587) |
120,707,597 |
|
- |
|
Lilly Endowment Inc |
10% Owner |
|
2018-08-07 |
4 |
S |
$103.22 |
$2,541,326 |
D/D |
(24,620) |
120,711,184 |
|
- |
|
Lilly Endowment Inc |
10% Owner |
|
2018-08-06 |
4 |
S |
$102.15 |
$19,918,860 |
D/D |
(195,000) |
120,735,804 |
|
- |
|
Lilly Endowment Inc |
10% Owner |
|
2018-08-02 |
4 |
S |
$99.52 |
$18,919,939 |
D/D |
(190,000) |
120,930,804 |
|
- |
|
Lilly Endowment Inc |
10% Owner |
|
2018-07-31 |
4 |
S |
$98.73 |
$20,240,873 |
D/D |
(205,000) |
121,120,804 |
|
- |
|
Tai Jackson P |
Director |
|
2018-07-26 |
4/A |
B |
$95.22 |
$149,305 |
D/D |
1,568 |
52,628 |
2.39 |
- |
|
Tai Jackson P |
Director |
|
2018-07-26 |
4 |
B |
$95.22 |
$206,437 |
D/D |
2,168 |
53,228 |
2.39 |
- |
|
Lilly Endowment Inc |
10% Owner |
|
2018-07-25 |
4 |
S |
$93.72 |
$17,999,259 |
D/D |
(190,000) |
121,325,804 |
|
- |
|
Lilly Endowment Inc |
10% Owner |
|
2018-07-24 |
4 |
S |
$90.76 |
$17,025,985 |
D/D |
(185,000) |
121,515,804 |
|
- |
|
Luciano Juan R |
Director |
|
2018-07-16 |
4 |
A |
$89.07 |
$9,709 |
D/D |
109 |
6,211 |
|
- |
|
Fyrwald J Erik |
Director |
|
2018-07-16 |
4 |
A |
$89.07 |
$5,433 |
D/D |
61 |
59,350 |
|
- |
|
Alvarez Ralph |
Director |
|
2018-07-16 |
4 |
A |
$89.07 |
$10,956 |
D/D |
123 |
40,968 |
|
- |
|
Lilly Endowment Inc |
10% Owner |
|
2018-07-06 |
4 |
S |
$87.44 |
$15,738,300 |
D/D |
(180,000) |
121,700,804 |
|
- |
|
Pusey Leigh Ann |
SVP, Corp. Affairs & Comm. |
|
2018-07-05 |
4 |
D |
$86.51 |
$65,056 |
D/D |
(752) |
1,642 |
|
- |
|
Pusey Leigh Ann |
SVP, Corp. Affairs & Comm. |
|
2018-07-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,394 |
2,394 |
|
- |
|
Lilly Endowment Inc |
10% Owner |
|
2018-07-05 |
4 |
S |
$86.62 |
$14,725,740 |
D/D |
(170,000) |
121,880,804 |
|
- |
|
Luciano Juan R |
Director |
|
2018-06-18 |
4 |
A |
$86.11 |
$9,644 |
D/D |
112 |
6,102 |
|
- |
|
Fyrwald J Erik |
Director |
|
2018-06-18 |
4 |
A |
$86.11 |
$5,425 |
D/D |
63 |
59,289 |
|
- |
|
1436 Records found
|
|
Page 34 of 58 |
|
|